⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL29560840 | 0.84 | — | — | |
| Isopropyl Alcohol SCHEMBL29432832 | 0.84 | — | — | |
| Isopropyl Alcohol SCHEMBL1686135 | 0.75 | — | — | |
| Isopropyl Alcohol SCHEMBL13994764 | 0.75 | — | — | |
| Isopropyl Alcohol SCHEMBL31348339 | 0.73 | — | — | |
| Isopropyl Alcohol SCHEMBL1686139 | 0.67 | — | — | |
| SCHEMBL30414484 | 0.67 | — | — | |
| Isopropyl Alcohol SCHEMBL15033448 | 0.57 | — | — | |
| SCHEMBL20797028 | 0.57 | — | — | |
| Isopropyl Alcohol SCHEMBL30467967 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4736856-A2 | BICYCLIC AMINES AS CDK2 INHIBITORS | Incyte Corporation (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4041731-B1 | BICYCLIC AMINES AS CDK2 INHIBITORS | INCYTE CORP (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260022119-A1 | BICYCLIC AMINES AS CDK2 INHIBITORS | INCYTE CORPORATION | 2026-01-22 | — | — | US | disclosed |
| US-12466828-B2 | Bicyclic amines as CDK2 inhibitors | INCYTE CORPORATION (US) | 2025-11-11 | — | — | US | disclosed |
| CN-119930610-A | Bicyclic amines as CDK2 inhibitors | 因赛特公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119930611-A | Bicyclic amines as CDK2 inhibitors | 因赛特公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-115298177-B | Bicyclic amines as CDK2 inhibitors | 因赛特公司 | 2025-01-17 | — | — | CN | disclosed |
| EP-4480479-A1 | PYRAZOLOPYRIDINE DERIVATIVE AND APPLICATION THEREOF IN MEDICINE | Xizang Haisco Pharmaceutical Co., Ltd. (CN) | 2024-12-25 | — | — | EP | disclosed |
| WO-2024222880-A1 | PHARMACEUTICAL COMPOSITION OF PYRIDO-PYRAZOLE DERIVATIVE AND USE OF PHARMACEUTICAL COMPOSITION IN MEDICINE | 西藏海思科制药有限公司 | 2024-10-31 | — | — | WO | disclosed |
| US-20240174664-A1 | BICYCLIC AMINES AS CDK2 INHIBITORS | INCYTE CORPORATION | 2024-05-30 | — | — | US | disclosed |
| US-20160251366-A1 | DEUTERATED AMLEXANOX | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2016-09-01 | — | — | US | disclosed |
| US-9365581-B2 | Deuterated amlexanox | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-06-14 | — | — | US | disclosed |
| EP-2991647-A1 | DEUTERATED AMLEXANOX | The Regents Of The University Of Michigan (US) | 2016-03-09 | — | — | EP | disclosed |
| US-20160060271-A1 | DEUTERATED AMLEXANOX | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2016-03-03 | — | — | US | disclosed |
| US-8946424-B2 | Deuterated amlexanox | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-02-03 | — | — | US | disclosed |
| US-20140329848-A1 | DEUTERATED AMLEXANOX | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-11-06 | — | — | US | disclosed |
| WO-2014179734-A1 | DEUTERATED AMLEXANOX | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2014-11-06 | — | — | WO | disclosed |
| US-20110129549-A1 | TRICYCLIC BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE DERIVATIVES AND USES THEREOF | CONCERT PHARMACEUTICALS, INC. | 2011-06-02 | — | — | US | disclosed |
| WO-2009145852-A1 | TRICYCLIC BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE DERIVATIVES AND USES THEREOF | CONCERT PHARMACEUTICALS, INC. (US) | 2009-12-03 | — | — | WO | disclosed |
| US-20080306151-A1 | DEUTERIUM-ENRICHED FENOFIBRATE | PROTIA, LLC (US) | 2008-12-11 | — | — | US | disclosed |